AXIM Biotechnologies (AXIM) Income Statement
151 Followers
AXIM Biotechnologies Income Statement
Last quarter (Q2 2026), AXIM Biotechnologies's total revenue was $206.99K. In Q2, AXIM Biotechnologies's net income was $-188.15K. See AXIM Biotechnologies’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 0.00 | $ 70.46K | $ 39.52K | $ 8.88K | $ 60.46K | |
| $ -427.37K | $ -369.27K | $ 39.52K | $ -417.25K | $ 60.46K | |
| $ 892.28K | $ 1.39M | $ 2.79M | $ 4.66M | $ 7.79M | |
| Depreciation and Amortization | $ 427.37K | $ 432.39K | $ 427.02K | $ 426.13K | $ 2.12M |
| $ -892.28K | $ -2.44M | $ -6.43M | $ -3.94M | $ -13.17M | |
| $ -1.32M | $ -1.76M | $ -2.75M | $ -4.65M | $ -7.99M | |
| $ 276.57K | $ -1.75M | $ -5.31M | $ -1.59M | $ -2.05M | |
| $ -1.04M | $ -3.51M | $ -8.06M | $ -6.24M | $ -16.02M | |
| $ -1.04M | $ -3.51M | $ -8.06M | $ -5.96M | $ -16.52M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.00 | $ -0.01 | $ -0.04 | $ -0.04 | $ -0.13 |
| Diluted EPS | $ -0.00 | $ -0.01 | $ -0.04 | $ -0.04 | $ -0.13 |
| Weighted Average Shares Outstanding | 340.46M | 318.90M | 227.69M | 165.47M | 131.54M |
| Weighted Average Shares Outstanding (Diluted) | 340.46M | 318.90M | 227.69M | 165.47M | 131.54M |
Currency in USD
